Sumitomo Pharma Co., Ltd. (OTCMKTS:DNPUF – Get Free Report)’s share price fell 7.7% on Tuesday . The company traded as low as $9.37 and last traded at $9.37. 750 shares traded hands during mid-day trading, a decline of 48% from the average session volume of 1,441 shares. The stock had previously closed at $10.15.
Sumitomo Pharma Stock Down 7.7%
The stock has a 50 day moving average of $11.70 and a two-hundred day moving average of $13.56.
About Sumitomo Pharma
Sumitomo Pharma Co, Ltd., trading OTC under the ticker DNPUF, is a global pharmaceutical company headquartered in Osaka, Japan. It engages in the research, development, manufacturing and marketing of prescription medicines. As part of the broader Sumitomo Group, the company applies integrated drug discovery platforms and collaborative partnerships to bring innovative therapies to market.
The company’s portfolio encompasses central nervous system disorders, oncology, immunology and regenerative medicine.
Featured Articles
- Five stocks we like better than Sumitomo Pharma
- Marvell Stock Soars on NVIDIA’s Trillion-Dollar Nod
- FirstCash Turns Pawn Into a Growth Machine
- HubSpot Just Crushed the Bear Case—Is a Bigger Rally Ahead?
- Aggressive Insider Buying Signals Opportunity in 3 Risky Stocks
Receive News & Ratings for Sumitomo Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sumitomo Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
